NASDAQ
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a interest coverage ratio of -13.75x as of Wednesday, July 15, 2026. This represents a 14.09% decrease compared to its 12-month average of -12.05x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.